SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX)
NBIX 141.80+0.6%Dec 31 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (409)1/5/2000 1:01:00 AM
From: scaram(o)uche  Read Replies (1) of 1834
 
going back and rereading, ain't biotech grand??......

(a) DPC. Janssen and Neurocrine, separately, grant to DPC an exclusive
worldwide license, with a right to grant sublicenses, under their
respective rights in and to the Janssen X-Patents and Neurocrine X-Patents
and under their respective interests in DPC X-Patents to make, have made,
use, sell, offer for sale, have sold and import certain X-Compounds, which
X-Compounds contain *************************************
************************************* as in formula ****************** and
formula ****** ************ where such ************************* is
otherwise **************************************** otherwise specifically
do not include a total of ******** compounds which may be
*********************************************************************** and
provided that said specifically ************************ were not
previously************************************************************* or
which may be ******** ************************* after ************** and
before *********** ****** ********************* and provided that said
specifically named **************** were not
************************************** in a written record before
**********************.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News